BACKGROUND: Penis cancer worldwide has an incidence of 0.51- 8.3 per 100 000 males. It is treatment can be surgical, conservative or radical, with adjuvant treatment radiotherapy and chemotherapy. The objectives were: to determine histologically the most common type of penile cancer, the place of involvement, and the most used surgical treatment. METHODS: It is a descriptive, retrospective study realized in Dr. Juan Tanca Marengo National Oncological Institute, between the periods of January 2010 to December 2015. Patients with a histopathological diagnosis of penile cancer were included; the variables studied were age, location, presence of lymph nodes, histopathology, recurrence, metastasis and surgery performed; the mean and standard deviation were obtained. For the statistical analysis Excel 2016 and SPSS were used. RESULTS: The patients studied were 58 with penile cancer; it was evidenced, in relation to age, an average of 59 years and standard deviation was obtained +/- 14.74. The lesion was located more frequently in the glans 41 %, followed by a total involvement of the penis with 38 %; in the case of the nodes they were palpable in 24 patients. The most frequent histological type was squamous cell carcinoma 67 %. The most used treatment was subtotal penectomy in 62 %. CONCLUSIONS: It was determined that squamous cell carcinoma was the most prevalent histological type, being located mainly in the glans; the technique most used was subtotal penectomy. It is recommended to pay attention early when there is evidence of a lesion at the level of the penis, the early treatment of these lesions improves the patient's prognosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.